Sky Century Investment (SKYI) Cash from Financing Activities (2012 - 2026)

Sky Century Investment's (SKYI) quarterly Cash from Financing Activities came in at $86222.0 in Q2 2026, up 729.7% year-on-year from $10392.0 in Q2 2025, and up 12043.94% on a QoQ basis from $710.0 in Q1 2026.

Sky Century Investment (SKYI) Cash from Financing Activities (2012 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 6 years of Cash from Financing Activities data on file, last reported at $86222.0 in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities rose 729.7% year-over-year to $86222.0 in Q2 2026; TTM through May 2026 was $111132.0, a 89.5% increase from a year earlier, with the FY2025 full-year figure at $46136.0, up 59.08% from the prior year.
  • Cash from Financing Activities for Q2 2026 stood at $86222.0, up from $710.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for SKYI reached as high as $86222.0 in Q2 2026 and fell as low as $710.0 in Q1 2026.
  • Historically, Cash from Financing Activities has averaged $21958.9 across 3 years, with a median of $11668.5 in 2024.
  • On a YoY basis, Cash from Financing Activities climbed as much as 729.7% in 2026 and fell as far as 97.15% in 2026.
  • Year by year, Cash from Financing Activities stood at $10827.0 in 2024, then soared by 123.52% to $24200.0 in 2025, then surged by 256.29% to $86222.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $86222.0 in Q2 2026, $710.0 in Q1 2026, and $24200.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Sky Century Investment 1.06 Mn 1.06 Mn 26,045.00 86,222.00

Historic Data

Download Data
DateValue
May 31, 2026 86,222.00
May 31, 2026 86,222.00
Feb 28, 2026 710.00
Feb 28, 2026 710.00
Nov 30, 2025 24,200.00
Nov 30, 2025 24,200.00
May 31, 2025 10,392.00
May 31, 2025 10,392.00
Feb 28, 2025 24,917.00
Feb 28, 2025 24,917.00
Nov 30, 2024 10,827.00
Nov 30, 2024 10,827.00
Aug 31, 2024 12,510.00
Aug 31, 2024 12,510.00
May 31, 2024 5,893.00
May 31, 2024 5,893.00
May 31, 2014 1,130.00
May 31, 2014 1,130.00
Nov 30, 2013 10,350.00
Nov 30, 2013 10,350.00